Fig. 7From: Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in gliomaRelationship between drug resistance and immunity in patients with glioma. a-b Correlation between risk score and immune checkpoints in glioma from CGGA and TCGA datasets. c-d Component types of the immune cells infiltrated into glioma are analyzed with CIBERSORT. e Representative images of IHC staining of CD163 and IBA1 in glioma samples from the CGGA cohort. f Quantification of expression levels of CD163 and IBA1 in IHC stainingBack to article page